MJC13
MJC13 is an FKBP52-targeted agent with anti-tumor activity that can be used in prostate cancer research[1].
Product Specifications
CAS Number
200709-97-3
UNSPSC
12352005
Hazard Statement
H302-H319
Target
FKBP
Related Pathways
Apoptosis; Autophagy; Cell Cycle/DNA Damage; Immunology/Inflammation
Field of Research
Cancer
Smiles
C1CCC(CC1)C(=O)NC2=C(C(=CC=C2)Cl)Cl
Molecular Formula
C13H15Cl2NO
Molecular Weight
272.17
Precautions
P264-P270-P280-P330-P501
References & Citations
[1]Su Liang, et al. Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer. Pharm Dev Technol. 2016;21 (1) :121-6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1476878 Inquire
Recombinant Kitasatospora griseola 1-deoxy-D-xylulose-5-phosphate synthase 1 (dxs1), partial
Sign In for Pricing
View Details orb3003964-01 20 µg
Recombinant Human Receptor-type tyrosine-protein phosphatase-like N (PTPRN), partial
Sign In for Pricing
View Details